Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Expression and significance of cyclooxygenase-2 mRNA in benign and malignant ascites.

Lu J, Li XF, Kong LX, Ma L, Liao SH, Jiang CY.

World J Gastroenterol. 2013 Oct 28;19(40):6883-7. doi: 10.3748/wjg.v19.i40.6883.

2.

Cyclooxygenase-2 expression in thyroid nodules.

Specht MC, Tucker ON, Hocever M, Gonzalez D, Teng L, Fahey TJ 3rd.

J Clin Endocrinol Metab. 2002 Jan;87(1):358-63.

PMID:
11788675
3.

[Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].

Zhan J, Tang XD.

Ai Zheng. 2002 Nov;21(11):1212-6. Chinese.

PMID:
12526218
4.

Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.

Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC.

Cancer Lett. 2003 Mar 10;191(2):223-7.

PMID:
12618337
5.

Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.

Kanaoka S, Yoshida K, Miura N, Sugimura H, Kajimura M.

Gastroenterology. 2004 Aug;127(2):422-7.

PMID:
15300574
6.

[Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].

Tátrai P.

Magy Onkol. 2008 Dec;52(4):379-83. doi: 10.1556/MOnkol.52.2008.4.7. Hungarian.

PMID:
19068466
7.

The expression and significance of feces cyclooxygensae-2 mRNA in colorectal cancer and colorectal adenomas.

Li X, Kong L, Liao S, Lu J, Ma L, Long X.

Saudi J Gastroenterol. 2017 Jan-Feb;23(1):28-33. doi: 10.4103/1319-3767.199112.

8.

Role of VEGF and CD44v6 in differentiating benign from malignant ascites.

Dong WG, Sun XM, Yu BP, Luo HS, Yu JP.

World J Gastroenterol. 2003 Nov;9(11):2596-600.

9.

[The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues].

Ren L, Hou SK, He LF, Ye HY, Guan KP.

Zhonghua Wai Ke Za Zhi. 2004 Sep 22;42(18):1104-7. Chinese.

PMID:
15498296
10.

High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.

Xi H, Baldus SE, Warnecke-Eberz U, Brabender J, Neiss S, Metzger R, Ling FC, Dienes HP, Bollschweiler E, Moenig S, Mueller RP, Hoelscher AH, Schneider PM.

Clin Cancer Res. 2005 Dec 1;11(23):8341-7.

11.
12.

Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer.

Hamaya Y, Yoshida K, Takai T, Ikuma M, Hishida A, Kanaoka S.

Br J Cancer. 2010 Mar 2;102(5):916-21. doi: 10.1038/sj.bjc.6605564. Epub 2010 Feb 9.

13.

Over-expression of COX-2 mRNA in colorectal cancer.

Roelofs HM, Te Morsche RH, van Heumen BW, Nagengast FM, Peters WH.

BMC Gastroenterol. 2014 Jan 2;14:1. doi: 10.1186/1471-230X-14-1.

14.

GnRH-II mRNA expression in tumor tissue and peripheral blood mononuclear cells (PBMCs) in patients with malignant and benign ovarian tumors.

Serin IS, Tanriverdi F, Ata CD, Akalin H, Ozcelik B, Ozkul Y, Kelestimur F.

Eur J Obstet Gynecol Reprod Biol. 2010 Mar;149(1):92-6. doi: 10.1016/j.ejogrb.2009.11.009. Epub 2009 Dec 16.

PMID:
20018426
15.

Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer.

Fujimura T, Ohta T, Kitagawa H, Fushida S, Nishimura GI, Yonemura Y, Elnemr A, Miwa K, Nakanuma Y.

J Surg Oncol. 1998 Oct;69(2):71-5.

PMID:
9808508
16.
17.
18.

Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry.

Hofland J, van Nederveen FH, Timmerman MA, Korpershoek E, de Herder WW, Lenders JW, Verhofstad AA, de Krijger RR, de Jong FH.

Clin Endocrinol (Oxf). 2007 Mar;66(3):335-40.

PMID:
17302865
19.

Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines.

Zhang S, Zhou X, Yu H, Yu Y.

BMC Cancer. 2010 Apr 27;10:163. doi: 10.1186/1471-2407-10-163.

20.

Prognostic relevance of cyclooxygenase-2 (COX-2) expression in Chinese patients with prostate cancer.

Bin W, He W, Feng Z, Xiangdong L, Yong C, Lele K, Hongbin Z, Honglin G.

Acta Histochem. 2011 Feb;113(2):131-6. doi: 10.1016/j.acthis.2009.09.004.

PMID:
19836060

Supplemental Content

Support Center